|
CORO1C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8783863353633E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.72113451163614E-12 |
| Normal-vs-Stage2 |
4.137000E-03 |
| Normal-vs-Stage3 |
6.92530477408582E-11 |
| Normal-vs-Stage4 |
6.94180002369649E-09 |
| Stage1-vs-Stage2 |
2.112400E-02 |
| Stage1-vs-Stage3 |
2.336200E-01 |
| Stage1-vs-Stage4 |
9.301900E-02 |
| Stage2-vs-Stage3 |
9.804100E-03 |
| Stage2-vs-Stage4 |
4.277500E-03 |
| Stage3-vs-Stage4 |
6.079200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.87148124459236E-14 |
| Normal-vs-AfricanAmerican |
2.191100E-04 |
| Normal-vs-Asian |
1.40000000037332E-07 |
| Caucasian-vs-AfricanAmerican |
3.153400E-01 |
| Caucasian-vs-Asian |
7.957200E-01 |
| AfricanAmerican-vs-Asian |
3.627800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4959999622709E-09 |
| Normal-vs-Female |
1.78557169050464E-12 |
| Male-vs-Female |
3.914000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.4168445023065E-12 |
| Normal-vs-Age(41-60Yrs) |
5.53849965889697E-10 |
| Normal-vs-Age(61-80Yrs) |
3.87120000500119E-08 |
| Normal-vs-Age(81-100Yrs) |
1.537900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.230750E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.364800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.837600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.792600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.717000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.020600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.224390E-01 |
| Classical-VS-Follicular |
1.62991842245219E-12 |
| Classical-VS-Other |
1.880960E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.83299997402742E-09 |
| Tall-VS-Other |
6.464400E-02 |
| Tall-VS-Normal |
2.22389999748884E-08 |
| Follicular-VS-Other |
2.000000E-01 |
| Follicular-VS-Normal |
1.624380E-01 |
| Other-VS-Normal |
2.900000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.58829999655319E-08 |
| Normal-vs-N1 |
3.40329999737321E-08 |
| N0-vs-N1 |
5.198100E-02 |
|
|
